CD11c+ macrophages are proangiogenic and necessary for experimental choroidal neovascularization

Patients with neovascular AMD (nAMD) suffer vision loss from destructive angiogenesis, termed choroidal neovascularization (CNV). Macrophages are found in CNV lesions from patients with nAMD. Additionally, Ccr2–/– mice, which lack classical monocyte–derived macrophages, show reduced CNV size. Howeve...

Full description

Bibliographic Details
Main Authors: Steven Droho, Amrita Rajesh, Carla M. Cuda, Harris Perlman, Jeremy A. Lavine
Format: Article
Language:English
Published: American Society for Clinical investigation 2023-04-01
Series:JCI Insight
Subjects:
Online Access:https://doi.org/10.1172/jci.insight.168142
_version_ 1797634334476206080
author Steven Droho
Amrita Rajesh
Carla M. Cuda
Harris Perlman
Jeremy A. Lavine
author_facet Steven Droho
Amrita Rajesh
Carla M. Cuda
Harris Perlman
Jeremy A. Lavine
author_sort Steven Droho
collection DOAJ
description Patients with neovascular AMD (nAMD) suffer vision loss from destructive angiogenesis, termed choroidal neovascularization (CNV). Macrophages are found in CNV lesions from patients with nAMD. Additionally, Ccr2–/– mice, which lack classical monocyte–derived macrophages, show reduced CNV size. However, macrophages are highly diverse cells that can perform multiple functions. We performed single-cell RNA-Seq on immune cells from WT and Ccr2–/– eyes to uncover macrophage heterogeneity during the laser-induced CNV mouse model of nAMD. We identified 12 macrophage clusters, including Spp1+ macrophages. Spp1+ macrophages were enriched from WT lasered eyes and expressed a proangiogenic transcriptome via multiple pathways, including vascular endothelial growth factor signaling, endothelial cell sprouting, cytokine signaling, and fibrosis. Additionally, Spp1+ macrophages expressed the marker CD11c, and CD11c+ macrophages were increased by laser and present in CNV lesions. Finally, CD11c+ macrophage depletion reduced CNV size by 40%. These findings broaden our understanding of ocular macrophage heterogeneity and implicate CD11c+ macrophages as potential therapeutic targets for treatment-resistant patients with nAMD.
first_indexed 2024-03-11T12:07:10Z
format Article
id doaj.art-ee798093a8ed40da9adba761f66c9a6f
institution Directory Open Access Journal
issn 2379-3708
language English
last_indexed 2024-03-11T12:07:10Z
publishDate 2023-04-01
publisher American Society for Clinical investigation
record_format Article
series JCI Insight
spelling doaj.art-ee798093a8ed40da9adba761f66c9a6f2023-11-07T16:25:25ZengAmerican Society for Clinical investigationJCI Insight2379-37082023-04-0187CD11c+ macrophages are proangiogenic and necessary for experimental choroidal neovascularizationSteven DrohoAmrita RajeshCarla M. CudaHarris PerlmanJeremy A. LavinePatients with neovascular AMD (nAMD) suffer vision loss from destructive angiogenesis, termed choroidal neovascularization (CNV). Macrophages are found in CNV lesions from patients with nAMD. Additionally, Ccr2–/– mice, which lack classical monocyte–derived macrophages, show reduced CNV size. However, macrophages are highly diverse cells that can perform multiple functions. We performed single-cell RNA-Seq on immune cells from WT and Ccr2–/– eyes to uncover macrophage heterogeneity during the laser-induced CNV mouse model of nAMD. We identified 12 macrophage clusters, including Spp1+ macrophages. Spp1+ macrophages were enriched from WT lasered eyes and expressed a proangiogenic transcriptome via multiple pathways, including vascular endothelial growth factor signaling, endothelial cell sprouting, cytokine signaling, and fibrosis. Additionally, Spp1+ macrophages expressed the marker CD11c, and CD11c+ macrophages were increased by laser and present in CNV lesions. Finally, CD11c+ macrophage depletion reduced CNV size by 40%. These findings broaden our understanding of ocular macrophage heterogeneity and implicate CD11c+ macrophages as potential therapeutic targets for treatment-resistant patients with nAMD.https://doi.org/10.1172/jci.insight.168142InflammationOphthalmology
spellingShingle Steven Droho
Amrita Rajesh
Carla M. Cuda
Harris Perlman
Jeremy A. Lavine
CD11c+ macrophages are proangiogenic and necessary for experimental choroidal neovascularization
JCI Insight
Inflammation
Ophthalmology
title CD11c+ macrophages are proangiogenic and necessary for experimental choroidal neovascularization
title_full CD11c+ macrophages are proangiogenic and necessary for experimental choroidal neovascularization
title_fullStr CD11c+ macrophages are proangiogenic and necessary for experimental choroidal neovascularization
title_full_unstemmed CD11c+ macrophages are proangiogenic and necessary for experimental choroidal neovascularization
title_short CD11c+ macrophages are proangiogenic and necessary for experimental choroidal neovascularization
title_sort cd11c macrophages are proangiogenic and necessary for experimental choroidal neovascularization
topic Inflammation
Ophthalmology
url https://doi.org/10.1172/jci.insight.168142
work_keys_str_mv AT stevendroho cd11cmacrophagesareproangiogenicandnecessaryforexperimentalchoroidalneovascularization
AT amritarajesh cd11cmacrophagesareproangiogenicandnecessaryforexperimentalchoroidalneovascularization
AT carlamcuda cd11cmacrophagesareproangiogenicandnecessaryforexperimentalchoroidalneovascularization
AT harrisperlman cd11cmacrophagesareproangiogenicandnecessaryforexperimentalchoroidalneovascularization
AT jeremyalavine cd11cmacrophagesareproangiogenicandnecessaryforexperimentalchoroidalneovascularization